Clinical Trial Search

Primary: Change in Scores on the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (MGH-CPFQ) — 27.5; 29; 22.6; 25 Scores on a scale

Primary: Acceptability — 3.91; 3.85 score on a scale

Primary: Safety Endpoint: The Rate of Major Complications After an Attempted ADO II AS Device Implant — 0; 2.8 percentage of participants

Primary: Attention Deficit Hyperactivity Disorder Total Symptom Score — 21.4; 30.0; 20.2; 29.7 units on a scale — p=<0.05

Primary: Diabetes Health Literacy Score — 1.30; 1.38 score on a scale — p=0.95

Primary: Change From Baseline to 8 Week Endpoint in Swanson, Nolan and Pelham Questionnaire (SNAP-IV): Attention-Deficit/Hyperactivity Disorder (ADHD) Subscale — 42.7; 41.5…

Primary: Change in HbA1c — -1.00; -0.32; -1.05; -0.35 Percentage of HbA1c — p=<.001

Primary: Binocular Distance Corrected Near Visual Acuity at Best Distance (That Which Provides the Subject With the Best Vision) — 0.07; 0.09 logMAR

Primary: Mean Power (EEG) During AFC and Placebo Challenge in ADHD and Control Groups — 3.19; 3.09; 3.50; 2.13 Mean Power (microvolts^2) — p=>0.05

Primary: Change From Baseline in Severity of Attention Deficit Hyperactivity (ADHD) Symptoms — -11.1; -18.2; -18.1 score on a scale

Primary: Swanson, Nolan, and Pelham Checklist for DSM-IV (SNAP)- Parent Rating of Inattention — 1.1; 1.7; 1.0; 1.3 Units on a scale

Primary: CASI-5 Parent-rated Composite Score — 1.49; 1.52; 1.18; 1.23 score on a scale

Primary: Change From Baseline in the HAMD-17 Total Score at Day 3 — -7.0; -8.9 score on a scale — p=0.0004

Primary: Change in Cognition and Psychopathology Disorders as Measured on the MATRICS Consensus Cognitive Battery (MCCB) — 14.1; 14.3 units on a scale